Too Old to Operate1 天
Bruton’s tyrosine kinase inhibition re-sensitizes multidrug-resistant DLBCL tumors driven ...
Disparate pathogenic mechanisms complicate precision-medicine efforts to treat diffuse large B-cell lymphoma (DLBCL), the most common lymphoma diagnosis. Though potentially curable with frontline ...
AB Science today provides an update on its masitinib platform
PRESS RELEASEAB SCIENCE PROVIDES AN UPDATE ON ITS MASITINIB PLATFORMParis, January 29, 2025, 7pm CETAB Science SA (Euronext - FR0010557264 - AB) ...